Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy

Lucilla Nobbio, Fulvia Fiorese, Tiziana Vigo, Michele Cilli, Gianfranco Gherardi, Marina Grandis, Roberto Cosimo Melcangi, Gianluigi Mancardi, Michele Abbruzzese, Angelo Schenone

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We investigated the contribution of Schwann cell-derived ciliary neurotrophic factor (CNTF) to the pathogenesis of Charcot-Marie-Tooth disease type 1A (CMT1A) and addressed the question as to whether it plays a role in the development of axonal damage observed in the disease, with aging. Ciliary neurotrophic factor was underexpressed in experimental CMT1A but not in other models of hereditary neuropathies. Sciatic nerve crush experiments and dosage of CNTF at different time points showed that expression of this trophic factor remained significantly lower in CMT1A rats than in normal controls; moreover, in uninjured CMT1A sciatic nerves CNTF levels further decreased with ageing, thus paralleling the molecular signs of axonal impairment, that is increased expression of non-phosphorylated neurofilaments and amyloid precursor protein. Administration of CNTF to dorsal root ganglia cultures reduced dephosphorylation of neurofilaments in CMT1A cultures, without improving demyelination. Taken together, these results provide further evidence that the production of CNTF by Schwann cells is markedly reduced in CMT1A. Moreover, the observations suggest that trophic support to the axon is impaired in CMT1A and that further studies on the therapeutic use of trophic factors or their derivatives in experimental and human CMT1A are warranted.

Original languageEnglish
Pages (from-to)441-455
Number of pages15
JournalJournal of Neuropathology and Experimental Neurology
Volume68
Issue number5
DOIs
Publication statusPublished - May 2009

Fingerprint

Ciliary Neurotrophic Factor
Charcot-Marie-Tooth Disease
Intermediate Filaments
Schwann Cells
Sciatic Nerve
Nerve Crush
Amyloid beta-Protein Precursor
Spinal Ganglia
Demyelinating Diseases
Therapeutic Uses
Axons

Keywords

  • Axonal impairment
  • Charcot-Marie-Tooth
  • Ciliary neurotrophic factor (CNTF)
  • CMT1A
  • Demyelination
  • DRG cultures
  • Neuroprotection
  • Peripheral myelin protein 22 (PMP22)
  • Schwann cells (SCs)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy. / Nobbio, Lucilla; Fiorese, Fulvia; Vigo, Tiziana; Cilli, Michele; Gherardi, Gianfranco; Grandis, Marina; Melcangi, Roberto Cosimo; Mancardi, Gianluigi; Abbruzzese, Michele; Schenone, Angelo.

In: Journal of Neuropathology and Experimental Neurology, Vol. 68, No. 5, 05.2009, p. 441-455.

Research output: Contribution to journalArticle

Nobbio, L, Fiorese, F, Vigo, T, Cilli, M, Gherardi, G, Grandis, M, Melcangi, RC, Mancardi, G, Abbruzzese, M & Schenone, A 2009, 'Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy', Journal of Neuropathology and Experimental Neurology, vol. 68, no. 5, pp. 441-455. https://doi.org/10.1097/NEN.0b013e31819fa6ba
Nobbio, Lucilla ; Fiorese, Fulvia ; Vigo, Tiziana ; Cilli, Michele ; Gherardi, Gianfranco ; Grandis, Marina ; Melcangi, Roberto Cosimo ; Mancardi, Gianluigi ; Abbruzzese, Michele ; Schenone, Angelo. / Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy. In: Journal of Neuropathology and Experimental Neurology. 2009 ; Vol. 68, No. 5. pp. 441-455.
@article{5eac5e3be1b04663ae6fd6712e103f05,
title = "Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy",
abstract = "We investigated the contribution of Schwann cell-derived ciliary neurotrophic factor (CNTF) to the pathogenesis of Charcot-Marie-Tooth disease type 1A (CMT1A) and addressed the question as to whether it plays a role in the development of axonal damage observed in the disease, with aging. Ciliary neurotrophic factor was underexpressed in experimental CMT1A but not in other models of hereditary neuropathies. Sciatic nerve crush experiments and dosage of CNTF at different time points showed that expression of this trophic factor remained significantly lower in CMT1A rats than in normal controls; moreover, in uninjured CMT1A sciatic nerves CNTF levels further decreased with ageing, thus paralleling the molecular signs of axonal impairment, that is increased expression of non-phosphorylated neurofilaments and amyloid precursor protein. Administration of CNTF to dorsal root ganglia cultures reduced dephosphorylation of neurofilaments in CMT1A cultures, without improving demyelination. Taken together, these results provide further evidence that the production of CNTF by Schwann cells is markedly reduced in CMT1A. Moreover, the observations suggest that trophic support to the axon is impaired in CMT1A and that further studies on the therapeutic use of trophic factors or their derivatives in experimental and human CMT1A are warranted.",
keywords = "Axonal impairment, Charcot-Marie-Tooth, Ciliary neurotrophic factor (CNTF), CMT1A, Demyelination, DRG cultures, Neuroprotection, Peripheral myelin protein 22 (PMP22), Schwann cells (SCs)",
author = "Lucilla Nobbio and Fulvia Fiorese and Tiziana Vigo and Michele Cilli and Gianfranco Gherardi and Marina Grandis and Melcangi, {Roberto Cosimo} and Gianluigi Mancardi and Michele Abbruzzese and Angelo Schenone",
year = "2009",
month = "5",
doi = "10.1097/NEN.0b013e31819fa6ba",
language = "English",
volume = "68",
pages = "441--455",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy

AU - Nobbio, Lucilla

AU - Fiorese, Fulvia

AU - Vigo, Tiziana

AU - Cilli, Michele

AU - Gherardi, Gianfranco

AU - Grandis, Marina

AU - Melcangi, Roberto Cosimo

AU - Mancardi, Gianluigi

AU - Abbruzzese, Michele

AU - Schenone, Angelo

PY - 2009/5

Y1 - 2009/5

N2 - We investigated the contribution of Schwann cell-derived ciliary neurotrophic factor (CNTF) to the pathogenesis of Charcot-Marie-Tooth disease type 1A (CMT1A) and addressed the question as to whether it plays a role in the development of axonal damage observed in the disease, with aging. Ciliary neurotrophic factor was underexpressed in experimental CMT1A but not in other models of hereditary neuropathies. Sciatic nerve crush experiments and dosage of CNTF at different time points showed that expression of this trophic factor remained significantly lower in CMT1A rats than in normal controls; moreover, in uninjured CMT1A sciatic nerves CNTF levels further decreased with ageing, thus paralleling the molecular signs of axonal impairment, that is increased expression of non-phosphorylated neurofilaments and amyloid precursor protein. Administration of CNTF to dorsal root ganglia cultures reduced dephosphorylation of neurofilaments in CMT1A cultures, without improving demyelination. Taken together, these results provide further evidence that the production of CNTF by Schwann cells is markedly reduced in CMT1A. Moreover, the observations suggest that trophic support to the axon is impaired in CMT1A and that further studies on the therapeutic use of trophic factors or their derivatives in experimental and human CMT1A are warranted.

AB - We investigated the contribution of Schwann cell-derived ciliary neurotrophic factor (CNTF) to the pathogenesis of Charcot-Marie-Tooth disease type 1A (CMT1A) and addressed the question as to whether it plays a role in the development of axonal damage observed in the disease, with aging. Ciliary neurotrophic factor was underexpressed in experimental CMT1A but not in other models of hereditary neuropathies. Sciatic nerve crush experiments and dosage of CNTF at different time points showed that expression of this trophic factor remained significantly lower in CMT1A rats than in normal controls; moreover, in uninjured CMT1A sciatic nerves CNTF levels further decreased with ageing, thus paralleling the molecular signs of axonal impairment, that is increased expression of non-phosphorylated neurofilaments and amyloid precursor protein. Administration of CNTF to dorsal root ganglia cultures reduced dephosphorylation of neurofilaments in CMT1A cultures, without improving demyelination. Taken together, these results provide further evidence that the production of CNTF by Schwann cells is markedly reduced in CMT1A. Moreover, the observations suggest that trophic support to the axon is impaired in CMT1A and that further studies on the therapeutic use of trophic factors or their derivatives in experimental and human CMT1A are warranted.

KW - Axonal impairment

KW - Charcot-Marie-Tooth

KW - Ciliary neurotrophic factor (CNTF)

KW - CMT1A

KW - Demyelination

KW - DRG cultures

KW - Neuroprotection

KW - Peripheral myelin protein 22 (PMP22)

KW - Schwann cells (SCs)

UR - http://www.scopus.com/inward/record.url?scp=69249140104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249140104&partnerID=8YFLogxK

U2 - 10.1097/NEN.0b013e31819fa6ba

DO - 10.1097/NEN.0b013e31819fa6ba

M3 - Article

VL - 68

SP - 441

EP - 455

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 5

ER -